Page 1 | Search Results | American Association for Cancer Research

1-20 of 219

Sort by

Sort Order Select

Journal Articles

Q&A: Owen Witte on Translational Research in Cancer

Blood Cancer Discov (2024) 5 (3): 136–138.

https://doi.org/10.1158/2643-3230.BCD-24-0069

Published: 01 May 2024

View article titled, Q&A: Owen Witte on Translational Research in Cancer

Journal Articles

Combating KRAS^G12C Inhibitor Resistance

Cancer Discov (2024) 14 (1): OF3.

https://doi.org/10.1158/2159-8290.CD-ND2023-0015

Published: 12 January 2024

View article titled, Combating KRASG12C Inhibitor Resistance

Journal Articles

Menin Inhibitors Trigger Leukemia Remissions

Cancer Discov OF1.

https://doi.org/10.1158/2159-8290.CD-ND2023-0019

Published: 14 December 2023

View article titled, Menin Inhibitors Trigger Leukemia Remissions

Journal Articles

CAR T-cell Availability for Multiple Myeloma Improving but Still Limited

Cancer Discov (2023) 13 (12): OF6.

https://doi.org/10.1158/2159-8290.CD-ND2023-0009

Published: 12 December 2023

View article titled, CAR T-cell Availability for Multiple Myeloma Improving but Still Limited

Journal Articles

Tumor-Agnostic Treatment Heading to the Clinic?

Cancer Discov (2023) 13 (12): OF10.

https://doi.org/10.1158/2159-8290.CD-ND2023-0013

Published: 12 December 2023

View article titled, Tumor-Agnostic Treatment Heading to the Clinic?

Journal Articles

UC Trials Get Standing Ovation

Cancer Discov (2023) 13 (12): 2496.

https://doi.org/10.1158/2159-8290.CD-ND2023-0014

Published: 12 December 2023

View article titled, UC Trials Get Standing Ovation

Journal Articles

Drugging RAS: Moving Beyond KRAS^G12C

Cancer Discov (2023) 13 (12): OF7.

https://doi.org/10.1158/2159-8290.CD-ND2023-0010

Published: 12 December 2023

View article titled, Drugging RAS: Moving Beyond KRASG12C

Journal Articles

EGFR-Mutant NSCLC: Spotlight on Amivantamab

Cancer Discov (2023) 13 (12): OF9.

https://doi.org/10.1158/2159-8290.CD-ND2023-0012

Published: 12 December 2023

View article titled, EGFR-Mutant NSCLC: Spotlight on Amivantamab

Journal Articles

Selpercatinib Shifts Treatment Paradigm for MTC and NSCLC

Cancer Discov (2023) 13 (12): OF8.

https://doi.org/10.1158/2159-8290.CD-ND2023-0011

Published: 12 December 2023

View article titled, Selpercatinib Shifts Treatment Paradigm for MTC and NSCLC

Journal Articles

ImmunoGen Takeover Caps Year of Record ADC Investments

Cancer Discov OF1.

https://doi.org/10.1158/2159-8290.CD-ND2023-0017

Published: 11 December 2023

View article titled, ImmunoGen Takeover Caps Year of Record ADC Investments

Journal Articles

Q&A: Olena Yefimenko on Cancer Care, Research in Ukraine

Cancer Discov (2023) 13 (10): 2115–2116.

https://doi.org/10.1158/2159-8290.CD-ND2023-0008

Published: 05 October 2023

View article titled, Q&A: Olena Yefimenko on Cancer Care, Research in Ukraine

Journal Articles

Q&A: Philip Greenberg on T Cells, IO's Future

Cancer Discov (2023) 13 (9): OF2.

https://doi.org/10.1158/2159-8290.CD-ND2023-0007

Published: 06 September 2023

View article titled, Q&A: Philip Greenberg on T Cells, IO's Future

Journal Articles

17th International Conference on Malignant Lymphoma: Key Takeaways

Blood Cancer Discov (2023) 4 (5): 342–345.

https://doi.org/10.1158/2643-3230.BCD-ND2023-0003

Published: 01 September 2023

View article titled, 17th International Conference on Malignant Lymphoma: Key Takeaways

Journal Articles

Q&A: Riccardo Dalla-Favera on Cancer Genetics

Blood Cancer Discov (2023) 4 (5): 339–341.

https://doi.org/10.1158/2643-3230.BCD-ND2023-0001

Published: 01 September 2023

View article titled, Q&A: Riccardo Dalla-Favera on Cancer Genetics

Journal Articles

MCED Testing Enters New Diagnostic Realms

Cancer Discov (2023) 13 (8): 1756.

https://doi.org/10.1158/2159-8290.CD-ND2023-0006

Published: 04 August 2023

View article titled, MCED Testing Enters New Diagnostic Realms

Journal Articles

Targeted Options for Glioma Looking Good

Cancer Discov (2023) 13 (8): 1755.

https://doi.org/10.1158/2159-8290.CD-ND2023-0004

Published: 04 August 2023

View article titled, Targeted Options for Glioma Looking Good

Journal Articles

Rare Lymphomas: Getting “a Bit Ahead”

Cancer Discov (2023) 13 (8): OF4.

https://doi.org/10.1158/2159-8290.CD-ND2023-0005

Published: 04 August 2023

View article titled, Rare Lymphomas: Getting “a Bit Ahead”

Journal Articles

Q&A: Robert Vonderheide on Immunotherapy Advances

Cancer Discov (2023) 13 (6): OF10.

https://doi.org/10.1158/2159-8290.CD-ND2023-0002

Published: 02 June 2023

View article titled, Q&A: Robert Vonderheide on Immunotherapy Advances

Journal Articles

UK Worker Shortages Extend Wait for Care

Cancer Discov (2023) 13 (6): 1282.

https://doi.org/10.1158/2159-8290.CD-ND2023-0003

Published: 02 June 2023

View article titled, UK Worker Shortages Extend Wait for Care

Journal Articles

Animal Alternatives OK'd by New Law

Cancer Discov (2023) 13 (4): 805.

https://doi.org/10.1158/2159-8290.CD-ND2023-0001

Published: 03 April 2023

View article titled, Animal Alternatives OK'd by New Law

NARROW

Q&A: Owen Witte on Translational Research in Cancer

Combating KRAS^G12C Inhibitor Resistance

Menin Inhibitors Trigger Leukemia Remissions

CAR T-cell Availability for Multiple Myeloma Improving but Still Limited

Tumor-Agnostic Treatment Heading to the Clinic?

UC Trials Get Standing Ovation

Drugging RAS: Moving Beyond KRAS^G12C

EGFR-Mutant NSCLC: Spotlight on Amivantamab

Selpercatinib Shifts Treatment Paradigm for MTC and NSCLC

ImmunoGen Takeover Caps Year of Record ADC Investments

Q&A: Olena Yefimenko on Cancer Care, Research in Ukraine

Q&A: Philip Greenberg on T Cells, IO's Future

17th International Conference on Malignant Lymphoma: Key Takeaways

Q&A: Riccardo Dalla-Favera on Cancer Genetics

MCED Testing Enters New Diagnostic Realms

Targeted Options for Glioma Looking Good

Rare Lymphomas: Getting “a Bit Ahead”

Q&A: Robert Vonderheide on Immunotherapy Advances

UK Worker Shortages Extend Wait for Care

Animal Alternatives OK'd by New Law

AACR Journals

AACR Journals

This Feature Is Available To Subscribers Only